KJT Welcomes Nicole Garberg, MS and Daniel Wasser, MD
KJT is excited to announce the addition of two talented professionals to our growing team. Nicole Garberg, MS joins us as Head of Real-World Evidence, while Daniel Wasser, MD assumes the role of Medical & Scientific Communications, VP. With their diverse backgrounds and proven expertise, they will play pivotal roles in further expanding KJT’s RWE and medical and scientific communication offerings.
Nicole Garberg has over 20 years of experience conducting research, generating insights and consulting with clients across a diverse set of industries. Her strong concentration within the health care industry has allowed her to advise clients and stakeholders across a broad spectrum of needs. Nicole’s expertise encompasses patient experience, patient reported outcomes, quality of life and unmet needs from each unique stakeholder lens within healthcare. More specifically, Nicole has extensively supported client organizations in medical technology and device, pharmaceuticals, biotechnology, provider organizations and payor groups. She has a proven track record of providing consultative insights that achieve business objectives, improve her clients’ performance and positively impact customer and patient experience. Nicole will shape KJT’s growing RWE offering serving as a thought partner to KJT’s clients by bringing the voice of the patient to every project and organization. Nicole holds a MS in Experimental Psychology from Central Michigan University and BA degrees in Psychology and Sociology from the University of St. Thomas.
Similarly, Dr. Wasser is an experienced medical director/strategist with a demonstrated history of working in the marketing and advertising industry. Having previously developed innovative omnichannel promotional content across a wide array of therapeutic areas, Dr. Wasser will be instrumental in evolving KJT’s scientific communication offerings, ensuring KJT can support clients in all aspects of medical communications and strategy. Dr. Wasser holds an MD from Tel Aviv University and graduated summa cum laude from Cornell University double-majoring in History and Neurobiology and Behavior.
“This marks a significant milestone for our organization as we welcome two exceptional leaders to our team. Their wealth of experience and visionary leadership are exactly what we need to navigate the complex business decisions for our pharmaceutical and biotech clients. In the coming months we will present further innovation and solutions for our clients in Medical Affairs which is truly exciting as we deepen our strategic relationships,” said Michaela Gascon, President and CEO of KJT.
